Abstract:Objective To analyze and compare the safety and efficacy of insulin detemir plus insulin aspart versus NPH plus insulin aspart in pregnant women with diabetes mellitus.Methods A total of 110 pregnant women who needed insulin treatment were enrolled in this study from Jan 1st,2013 to Dec 31st,2014,including pre-pregnant diabetes mellitus (PGDM,n=50) and gestational diabetes mellitus (GDM,n=60).All these subjects were randomly divided by 1:1 into two groups:insulin detemir plus insulin aspart group (Det group,n=55) and NPH plus insulin aspart group (NPH group,n=55).The changes of plasma glucose levels,time for reaching plasma glucose targets,incidence of hypoglycemia and pregnancy outcomes after the treatment were compared between the two groups.Results After one week of treatment,the mean 2 h post-meal plasma glucose levels were lower in Det group than in NPH group[(6.9±0.9) vs (7.6±1.1) mmol/L,P=0.001].The time for achieving FPG target,2 hPG target and both FPG target and 2 hPG target were shorter in Det group than in NPH group[(7.1±3.2) vs(4.8±2.9) d,(8.7±3.0) vs (5.7±3.6) d,(10.9±2.8) vs (6.8±4.1) d;all P=0.000].The incidence of hypoglycemia was 10.9% in Det group and 25.5% in NPH group(P<0.05).However,there were no significant differences in delivery week,the incidence of cesarean,pregnancy hypertention,the prevalence of macrosomia,the neonatal hypoglycemia,hyperbilirubinemia,and neonatal weight and transfering to NICU between the two groups (P>0.05).Conclusion insulin detemir plus insulin aspart is more effective in blood glucose control in pregnant women with DM.It can decrease injection times and the incidence of hypoglycemia,without increasing adverse pregnant outcomes.

Safety and efficacy of insulin detemir plus insulin aspart in pregnant women with diabetes mellitus